MSMB gene rs10993994 polymorphism increases the risk of prostate cancer

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Genome-wide association studies (GWASs) identified microseminoprotein-β (MSMB) gene rs10993994 polymorphism was significantly associated with prostate cancer (PC) risk. However, the association between MSMB gene rs10993994 polymorphism and PC risk remains controversial. Therefore, we performed a systematic review and meta-analysis by searching in the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fixed-effect or random-effect models. A total of 11 publications containing 13 case-control studies for rs10993994 polymorphism were included in our analysis. Our data indicated that MSMB gene rs10993994 polymorphism was associated with an increased risk of PC. Stratification analyses of ethnicity suggested rs10993994 polymorphism increased the risk of PC among Caucasians, but not among Asians. In conclusion, this meta-analysis indicates that MSMB gene rs10993994 polymorphism increases the risk of PC.

Cite

CITATION STYLE

APA

Peng, T., Zhang, L., Zhu, L., & Mi, Y. Y. (2017). MSMB gene rs10993994 polymorphism increases the risk of prostate cancer. Oncotarget, 8(17), 28494–28501. https://doi.org/10.18632/oncotarget.15312

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free